Related Experiment Video
Updated: Apr 29, 2026
11:34
Breathing-controlled Electrical Stimulation BreEStim for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013
25.3K
Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current
Tracey A Ignatowski1, Robert N Spengler, Krishnan M Dhandapani
1Department of Pathology and Anatomical Sciences and Program for Neuroscience, School of Medicine and Biomedical Sciences, The State University of New York, Buffalo, NY, USA.
CNS Drugs
|May 28, 2014
Summary
Etanercept, a treatment neutralizing tumor necrosis factor (TNF), shows promise in improving long-term stroke-related neurological and cognitive deficits. This therapy targets chronic neuroinflammation and TNF, offering a new direction for post-stroke recovery.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Tumor necrosis factor (TNF) is increasingly implicated in stroke pathophysiology and chronic brain dysfunction.
- TNF modulates synaptic function and contributes to neuropathic pain.
- Chronic neuroinflammation, marked by microglial activation, is observed post-stroke.
Purpose of the Study:
- To evaluate the efficacy of etanercept in treating chronic post-stroke neurological and cognitive dysfunction.
- To explore the therapeutic potential of neutralizing TNF in stroke recovery.
Main Methods:
- Observational studies involving perispinal administration of etanercept.
- Assessment of neurological and cognitive outcomes post-treatment.
- Review of existing evidence on TNF inhibition and stroke outcomes.
Main Results:
- Recent studies report rapid and sustained improvement in chronic post-stroke neurological and cognitive dysfunction with perispinal etanercept.
- Etanercept demonstrated reduction in cognitive dysfunction, neuropathic pain, and microglial activation in related studies.
- The causal link between etanercept and reduced post-stroke disability is supported by Bradford Hill Criteria.
Conclusions:
- Perispinal etanercept offers a potential therapeutic strategy for chronic post-stroke neurological and cognitive deficits.
- Targeting chronic microglial activation and pathological TNF levels presents a novel research and treatment avenue for stroke recovery.
- Etanercept's mechanism aligns with established criteria for causality in therapeutic interventions.
